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Robert Koch had discovered the pathogen of tuberculosis (TB) in
1882, many still believed that TB, like smallpox, could be eliminated
by the end of the millennium from the group of infectious diseases
afﬂicting humanity. This optimistic approach was supported by the
spectacular 20th-century results in the prevention, diagnostics and
therapy of the disease. Sadly, these predictions did not come true.
Instead of being eradicated, TB re-emerged at the end of the 20th
century to become a global health threat for the new millennium.
According to the latest WHO's data, TB remains one of the
world's deadliest contagious diseases despite slowly declining each
year. In 2013, an estimated 9 million people developed TB and 1.5
million died from the disease, 360,000 of whomwere HIV-positive.
A global 3.5% multi-drug resistance rate was observed. Of the
estimated 9 million TB cases, more than half (56%) were in the
South-East Asia and Western Paciﬁc regions. A further one quarter
were in the African region, which also had the highest rates of cases
and deaths relative to population. India and China alone accounted
for 24% and 11% of total cases respectively [2].
Tuberculosis remains a major global health problemworldwide.
Despite the advent of antibiotics which have widely reduced
mortality, antibiotic-resistant strains have now emerged, with
multi-resistant strains raising therapeutic problems reminiscent of
pre-antibiotherapy clinical situations dating from the turn of the
19th and 20th centuries. This reminder of history prompts us to
increase our knowledge both of the origin and evolutionary history
of TB and of the factors promoting the emergence and spread of TB
strains in human populations worldwide.
Fifteen years after the ﬁrst multidisciplinary TB meeting ICEPT
(“International Congress on The Evolution and Paleoepidemiology
of Tuberculosis”; September 1997, Budapest-Szeged, Hungarye see
more details in [1]), a further TB Evolution Meeting (ICEPT2) was
held in Szeged, Hungary between the 22nd and 25th of March 2012
to gather an updated multidisciplinary synthesis of the* Corresponding author.
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of TB evolutionary biology and the spectacular results produced by
the new interdisciplinary collaborations initiated during the ﬁrst
ICEPT demanded a new synthesis of these topics. Several important
questions were addressed during ICEPT2, among them: what is the
oldest evidence of this infection on human and animal remains?
When did speciﬁc mutation(s) of the modern strains arise? What
was the relative importance of the different pathogenic species of
the Mycobacterium genus among past populations? Can we
reconstruct a consensual phylogeny of the Mycobacterium genus?
How can paleopathology and paleomicrobiology contribute to the
research on TB evolution? What are the main strategies to stop or to
moderate the re-emergence of TB? How can molecular phyloge-
netics contribute to these ﬁghts? The most up-to-date answers to
these questions are providing in this Special Issue of Tuberculosis,
which gathers the results of the 2012 ICEPT2 TB Evolution Meeting.
When choosing the dates of the 2012 TB Evolution Meeting, it
was decided to join the Albert Szent-Gy€orgyi's Nobel Prize Award
Anniversary Conference Series (23rd-25th March 2012, University
of Szeged, Szeged, Hungary) and the International TB day (24th
March 2012), corresponding to the 130th anniversary of Robert
Koch's discovery. This Conference Series therefore also beneﬁtted
from the presence of nine Nobel Prize winners.
The ﬁrst chapter of this special issue is dedicated to the past of
TB - and TB in the Past. It is currently usually assumed that most
major infectious diseases could have only emerged within the last
ten thousand years, following the rise of agriculture and domesti-
cation and the growth of human populations during the Neolithic
period. Human TB could be an environmental (zoonotic) disease,
e.g. derived from animal TB ormay have developed gradually by co-
evolution, specialization and adaptation towards pathogenicity and
virulence of human-adapted bacteria. In this special issue, analysis
of skeletons coming from the early Neolithic site of Dja'de el
Mughara (11th millenium BP) can now reveal that human tuber-
culosis predated domestication in ancient Syria (Baker et al.),
occurring at a site showing only the earliest signs of wild aurochs
(Bos primigenius) domestication. Interestingly, archaeological signs
of settlement during the 9th millennium BC are restricted to the
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able in this area provide adequate material to test the early pres-
ence of Mtb complex pathogens. Few studies have been completed
on human and animal remains, so the opportunity to test the hy-
pothesis of a co-evolution rather than a direct transmission from
bovines to humans is not yet possible. However, we cannot exclude
that TB may also been contracted from wild or feral animals
(Minnikin et al.). In that case, phylogeographical speciﬁcity of
ancient wildlife and various food regimens may have played a role.
With the assumption of a human Mycobacterium tuberculosis
ancestor, the question of TB identiﬁcation in Upper Paleolithic
modern humans if not among Neanderthals can now be asked.
The vast majority of infectious diseases only affect the soft tis-
sues of the body. In the case of TB, only a small proportion of pa-
tients (3e5%) develops bone stigma. It is therefore a great challenge
to analyze and detect speciﬁc bone lesions to target samples of
interest. The remarkable bone changes indicative of a long-
standing chronic disease (Pott's disease) would have been un-
likely to develop until the infection was less virulent. Until now,
paleopathology was limited to the identiﬁcation of this small pro-
portion of individuals carrying such speciﬁc lesions, having suf-
fered from TB for an extensive period of time. Fortunately,
mycobacteria are suitable targets for paleopathological and bio-
molecular studies because of their waxy, hydrophobic and lipid-
rich cell wall (Daffe) that seems to help to protect DNA against
destruction and degradation. New approaches combining
morphological studies (minor osteological lesions, microscopic
changes) with biochemical and molecular analyses of biological
traces in bones (speciﬁc lipid biomarkers, proteins, DNA) provide
promising results with the detection and identiﬁcation of ancient
TB infection (e.g. Donoghue et al.; Hershkovitz et al.; Masson et al.;
Molnar et al.; Palﬁ et al.; Santos; Schmidt-Schultz and Schultz;
Schultz and Schmidt-Schultz).
Paleopathological processes of TB infection can also be better
understood by 3D imaging (Coqueugniot et al.). Information is now
also available on TB strains which had infected ancient human
populations in different geographic regions. Furthermore, new
methods can now address paleoepidemiological questions about
the prevalence and distribution of infection diseases in past pop-
ulations (Blondiaux and Naji; Eddy; Teschler-Nicola et al.). New
studies using themolecular analysis identiﬁcation ofM. tuberculosis
in prehistoric and historic populations between 5000 BC and 1800
AD give a more complete view on the infection rates in ancient
times (Masson et al.; L€osch et al.; Posa et al.; Szikossy et al.). They
also provide information about the molecular evolution and the
phylogenetic relationships of infectious diseases through the
identiﬁcation of possible TB strains no longer found today as well as
the comparative analysis of modern and ancient microbial se-
quences (Roberts; Spigelman et al.).
More than 2000 modern MTB genomes have been sequenced to
date, affording a more accurate reconstruction and calibration of
the evolutionary scheme of M. tuberculosis helping to evaluate the
distribution and prevalence of ancient strains occurring both in
ancient and modern populations. It must be stressed that such
studies do not necessarily demonstrate the proportion of in-
dividuals that died from TB, but rather the proportion that had
contracted TB at some stages of their lives. Knowledge of changing
prevalence in the past helps epidemiologists to understand the
effect of environmental and socio-cultural factors affecting infec-
tious diseases at a time before antibiotics and other modern in-
terventions (Matos and Santos; Roberts and Bernard).
Ancient biomolecular analyses, including new sequencing
technologies (next-generation sequencing), could signiﬁcantly
contribute to calibrate, improve or even change current models
about TB evolution and the spread of MTb complex strains.Identifying the place of origin and later spread of TBwithin humans
and animals whether wild or under domestication can shed light
on its evolutionary process (Lee et al.). A genetic factor is not the
only cause for the (re-)emergence of TB, as others must also be
considered such as international travel and trade, poor economic
environment, demographic (human population increase) and
socio-cultural factors (urbanization), a weak health system,
together with worldwide human migrations and community of
pathogens (Donoghue et al.). Several studies have provided evi-
dence for a role of the host genetics in susceptibility to TB, while
numerous candidate genes studies as well as genome-wide linkage
scans have been carried out. However, some inconsistencies are
noticeable across these studies. In fact, different key elements
should be accounted for when conducting forthcoming studies:
deﬁnition of the controls is clearly questioned (are they true con-
trols or latently infected with tuberculosis?), population substruc-
ture (admixture) and differences in M. tuberculosis strains (Perrin).
TB is caused by a group of phylogenetically closely related bac-
teria, known as the M. tuberculosis complex (MTBC). What are the
potential evolutionary consequences of such long-standing
humanepathogen association? How was TB “seeded” in human
populations and when? These questions remain open. Whole-
modern genome sequencing, systems biology and hostepathogen
interactions are generating new approaches for the understanding
of the past and and ongoing evolution, as well as the pathogenicity,
of M. tuberculosis. CRISPR (Clustered Regularly Interspersed Short
Palindromic Repeats), which demonstrate a historical record of
bacterial-phage struggle, have been valuable in the past. Combined
to new multi-level SNP-based identiﬁcation tools, they should
remain useful in the future, helping to follow both the microevo-
lution and macroevolution process of MTBC (Sola).
Studies have shown human pathogens to have geographic
structures in terms of population genetics. Depending on a splitter/
gatherer point of view, the global population structure of
M. tuberculosis complex is deﬁned by six to ten phylogeographical
lineages, each associated with speciﬁc human populations (sym-
patric). The links between the particular MTBC lineages and human
populations are maintained in cosmopolitan settings. Transmission
of allopatric strains has been associated with risk factors such as
HIV-co-infection. One of the key features of co-evolution is the
ongoing evolutionary arms race between the pathogen and the host
immune system. Surprisingly, the known human T-cell epitopes of
MTBC are the most conserved regions of the MTBC genome and
might contribute to the successful spread of MTb. “Ancient” and
“modern” lineages can be distinguished among the six main
human-adapted lineages (East-African Indian, Beijing, Central-
Asian, Euro-American, M. africanum, M. bovis). The three “mod-
ern” lineages are more successful in terms of their geographical
spread i.e. Europe, China and India. Some studies are consistent
with the hypothesis that such strains have evolved a strategy of
higher virulence and shorter latency (Mokrousov; Gomes et al.;
Simeone et al.). The ﬁght againstM. tuberculosis also requires better
diagnostic platforms (Somosk€ovi et al.) and new therapeutic ap-
proaches (Sipos et al., Horvati et al.). Although the complexity of the
co-evolutionary process is difﬁcult to understand, it is key to pre-
dicting progressive genetic changes in the future and developing a
more integrative view (Perrin).
Questions about the origins and spread of tuberculosis in the
past are addressed, in addition to biological and genetic topics, as
well as epidemiological problems of the present. A thorough syn-
thesis or concise summary of the articles from such a great number
of ﬁelds cannot be given here. The emphasis will be different for a
paleopathologist and for a microbiologist, just as a clinician and a
medical historian approach the evolution of TB in diverse ways.
Nevertheless, we remain convinced that the study of TB through an
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including ﬁndings from paleopathology to paleogenetics and from
modern diversity studies to diagnostics, offers the best potential to
signiﬁcantly improve our knowledge of TB and its continuing
evolution. This special issue represents a small yet signiﬁcant
contribution to the global effort to reduce and hopefully eventually
completely eradicate TB infections worldwide. We sincerely believe
that by reading this TB Evolution special issue, the general reader
will get a comprehensive picture of the issues related to the past
and present of Tuberculosis, while the student of its evolution will
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